Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy

Massimiliano Lanzafame, Sergio Ferrari, Emanuela Lattuada, Fabiana Corsini, Roberto Deganello, Sandro Vento, Ercole Concia

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We describe the clinical course of an HIV-infected patient with progressive multifocal leukoencephalopathy who took mirtazapine for his depression. After six months of therapy the clinical symptoms had not worsened and the neuroradiological image of the brain was unchanged. Further studies are necessary to determine the effect of serotonin receptor antagonist in treating PML associated to HIV.

Original languageEnglish
Pages (from-to)35-37
Number of pages3
JournalInfezioni in Medicina
Volume17
Issue number1
Publication statusPublished - Mar 1 2009

Keywords

  • Depression
  • HIV infection
  • Mirtazapine
  • Progressive multifocal leukoencephalopathy

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy'. Together they form a unique fingerprint.

  • Cite this

    Lanzafame, M., Ferrari, S., Lattuada, E., Corsini, F., Deganello, R., Vento, S., & Concia, E. (2009). Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. Infezioni in Medicina, 17(1), 35-37.